Dexamethasone Mouthwash

Approved

WWoman's

Dexamethasone Mouthwash is one of 43 therapeutic programs targeting Stomatitis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

StomatitisRecruiting

Oral MucositisRecruiting

StomatitisApproved

Recruiting

Oral MucositisApproved

Recruiting

Competition

Competitive Landscape

132 competitors in Oral Mucositis

#DrugCompanyPhaseTrials

Afinitor

Novartis

Phase 3

1 2

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

3 3

Cytoxan

BBaxter Healthcare Corporation

Phase 3

2 4

Duragesic

CCephalon

Phase 3

2 5

Bactroban

PPadagis LLC

Phase 3

1 6

Neurontin

VViatris Specialty LLC

Phase 3

1 7

Benadryl

PParkedale

Phase 3

1 8

Curcumin

Merck & Co.

Phase 3

2 9

N-Acetyl Cyteien

SStanford University

Phase 3

2 10

Alpha Lipoic Acid

NNational Center for Complementary and Integrative Health (NCCIH)

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

ApprovedRecruiting

Oral Mucositis

NCT07287826

ApprovedRecruiting

Stomatitis

NCT07357597

Clinical

Trials by Indication[1]

Stomatitis1 trial

A Phase IV, Open-Label, Single-Arm Study of Prophylaxis for Datopotamab Deruxtecan-related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer (TROPION-SWISH)

Recruiting· AstraZeneca logo

AstraZeneca·Approved·NCT07357597·100 enrolled

Oral Mucositis1 trial

Study for Dexamethasone Mouthwash in Lowering Episodes of Oral Mucositis Among Patients With Cancer: The SMILE Study

Recruiting·WWoman's·Approved·NCT07287826·45 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Dexamethasone Mouthwash. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Dexamethasone Mouthwash. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Woman's company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Approved[1]
Company: WWoman's

Dexamethasone Mouthwash

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Stomatitis1 trial

Oral Mucositis1 trial

References

Drug Info

Quick Facts

Related News